FISH Plus Cytology Beats Cytology Alone for Neoplasia Detection

This article originally appeared here.
Share this content:
FISH + Cytology Beats Cytology Alone for Neoplasia Detection
FISH + Cytology Beats Cytology Alone for Neoplasia Detection

(HealthDay News) -- For patients with diverse pathologies who undergo endoscopic ultrasonography with fine-needle aspiration, adding fluorescence in situ hybridization (FISH) detection methods to conventional cytology improves the sensitivity of cytology alone for detection of neoplastic lesions, according to a study published in the May issue of Gastroenterology.

To compare the accuracy of conventional cytology with that achieved using digital image analysis and FISH methods to detect neoplasia, Michael J. Levy, MD, of the Mayo Clinic in Rochester, MN, and his colleagues conducted a prospective study using at least 6 fine-needle aspiration samples from each of 250 patients, collected during endoscopic ultrasonography.

The researchers tested samples collected from the lymph nodes, pancreas, gastrointestinal lumen wall, periluminal mass, liver, and other miscellaneous sites. Digital image analysis demonstrated a potential lack of utility. FISH combined with conventional cytology was 11% more sensitive than cytology alone in detecting malignancy (P=0.0002), but its specificity was reduced from 100 to 96%.

"FISH analysis significantly enhanced the diagnostic sensitivity over conventional cytology alone, despite limited tissue sampling," the authors write. "Our data support the contention that the majority of tested cancers harbor chromosomal alterations, irrespective of the underlying histology."

One author and affiliation disclosed holding a patent and receiving royalties from the sale of the FISH probe set (UroVysion) discussed in this study.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs